Companies › CNSP

CNS PHARMACEUTICALS INC (CNSP)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001729427 · EDGAR filings · Updated 2026-07-02

CNS PHARMACEUTICALS INC (CNSP) has reported institutional ownership of 17.9%, with 11 institutional managers holding positions valued at $348.7K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-02 — Current report (8-K) filed
• 2026-05-26 — EFFECT filed
• 2026-05-26 — Prospectus supplement (424B3) filed
• 2026-05-20 — Insider transaction reported (Form 4)
• 2026-05-19 — D filed
• 2026-05-19 — Shelf registration (S-3) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CNS PHARMACEUTICALS INC has 11 institutional holders and institutional ownership of 17.9%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 0 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

ACLARION INC (ACON) · Aspire Biopharma Holdings Inc (ASBP) · ALAUNOS THERAPEUTICS INC (TCRT) · MOLECULIN BIOTECH INC (MBRX) · KAIROS PHARMA LTD (KAPA) · NexGel Inc (NXGL)